Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 2123213

Partner notification for HIV control.

F N Judson
View original source ↗Export metadata ↓

Abstract

Long used as a public health tool for controlling sexually transmitted diseases, partner notification has been underutilized against HIV infection. Why? Issues of confidentiality, cost-effectiveness, and clinical benefit are involved. The validity of these concerns is addressed in a review of recent experience in Colorado and elsewhere.

Explore related subjects

AIDS SerodiagnosisColoradoConfidentialityCost-Benefit AnalysisHIV InfectionsHIV-1HumansMass ScreeningPrevalenceProgram EvaluationPublic HealthSexual PartnersTruth DisclosureJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F N Judson. 1990-12-15. Partner notification for HIV control.. https://pubmed.ncbi.nlm.nih.gov/2123213/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

Bacterial pyomyositis in the United States.

The incidence of reported bacterial pyomyositis is increasing in the United States, especially among immunocompromised persons. This review summarizes all reported cases of pyomyositis among human immunodeficiency virus (HIV)-infected persons worldwide and HIV-negative persons in the United States since 1981. During the era of combination antiretroviral therapy, bacterial pyomyositis among HIV-infected persons typically occurred in those with end-stage acquired immunodeficiency syndrome. Among non-HIV-infected patients, about half have a serious underlying medical problem, most commonly diabetes mellitus, malignancy, or a rheumatologic condition. These patients are more likely to have a gram-negative infection, a normal white blood cell count, multifocal involvement, or higher mortality than those without an underlying medical condition. The characteristics of cases in temperate areas are similar to tropical cases, except that the former occurs more often in immunocompromised persons; this may change with the HIV epidemic in tropical regions.

AIDS Serodiagnosis↗